- US equities grind lower amid cautious sentiment ahead of the key US CPI.
- US 10-year Treasury yield drops to the lowest since March.
- GameStop declines after market on firm’s rejection to forward guidance.
- US-China tussles escalate, challenges for tech sector identified.
Given the risk sensitivity over ahead of the key data/event, US shares remained on the back foot by the end of Wednesday’s North American trading session. The sentiment could also be traced to a lack of major catalysts even as the Sino-American tensions grow stronger.
Market’s measures of volatility, Volatility Index (VIX), dropped to the lowest in over a year amid cautious sentiment as traders await the US Consumer Price Index (CPI) amid mixed clues. Also on the wait-list is the European Central Bank’s (ECB) monetary policy meeting. The ECB is less likely to entertain markets, except for being important due to the economic guidance, whereas the battle between the early signals of the US CPI and the Fed’s rejection to reflation fears wobble investors.
It’s worth noting that the US Senate’s passage of a $200 billion bill to ward off reliance on some of the Chinese technology joins the latest push by the US antitrust lawmakers to weigh on the big technology firms to weigh on the sentiment. Even so, “meme” stocks remained volatile and so do the US bonds.
Against this backdrop, Dow Jones Industrial Average (DJI) dropped 0.44% or 152.68 points to 34,447.14 whereas S&P 500 came in second with 0.18% downside, or 7.71 points, to 4,219.55. Nasdaq also posted losses on the day, down 0.09% or 13.16 points to 13,911.75.
Drugmakers like Pfizer and Merck benefited from US President Joe Biden’s covid vaccine donation plans whereas the social-media-frenzy ace GameStop couldn’t cheer upbeat earnings, -$0.45 EPS versus -$0.71 expected, as the firm keeps refraining from forwarding guidance. Further, shares of AMC and Bed Bath & Beyond also closed lower.
It’s worth noting that the steady US Wholesale Inventories and upbeat MBA Mortgage Applications couldn’t entertain traders ahead of the week’s crucial events.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.